Developer docs
API playgroundTry for free, no card

Search company profiles

Boston University Chobanian & Avedisian School of Medicine

Full company profile

uuid0000zyf

Namestring
Boston University Chobanian & Avedisian School of Medicine
Legal namestring
Boston University Chobanian & Avedisian School of Medicine
Websiteurl
bumc.bu.edu
Company typeenum
Private
Founded yearint
1848
Descriptiontext

Boston University Chobanian & Avedisian School of Medicine is a private nonprofit academic medical institution founded in 1848 as New England's first medical school, operating within Boston University's Medical Campus in the historic South End of Boston. The school delivers medical education through MD and graduate programs (Graduate Medical Sciences), trains nearly 3,800 students, and employs 2,900+ full-time, part-time, affiliate, and volunteer faculty. Its research portfolio is anchored by flagship facilities including the National Emerging Infectious Diseases Laboratories (NEIDL), the Center for Regenerative Medicine (CReM), a cryoEM facility equipped with a Glacios-2 system, and the Framingham Heart Study, the nation's longest-running cardiovascular cohort study at 75+ years. Boston Medical Center, the school's primary teaching affiliate and a safety-net hospital, provides clinical training sites and serves as the main venue for community health service delivery focused on underserved populations.

The school's revenue model is multi-stream and characteristic of nonprofit academic medical centers: (1) tuition and fees from MD and graduate programs billed annually with financial aid support; (2) federal research funding, predominantly from NIH grants supporting work in Alzheimer's genetics, infectious diseases, and other areas; and (3) clinical care revenue flowing through Boston Medical Center as the primary teaching affiliate. The institution has secured major grant funding including a $13.7M NIH award for Alzheimer's genetic research and a $3.9M NIH grant for Alzheimer's therapeutics. A landmark $100 million naming gift from alumnus Edward Avedisian in 2022, the largest in school history, expanded endowed professorships, financial aid, and research initiatives. The school's go-to-market is direct-to-consumer in education (admissions-based enrollment) and enterprise in research (federal grants and institutional collaborations), with clinical services distributed through Boston Medical Center and affiliated community health centers including Codman Square Health Center and DotHouse Health.

The institution is led by a faculty of internationally recognized researchers, including Nobel laureate Drew Weissman (mRNA technology, 2023 Nobel Prize in Physiology or Medicine) as an alumnus and Nancy Sullivan (Ebola vaccine pioneer) as director of NEIDL. Recent strategic leadership appointments include Donald M. Lloyd-Jones as Framingham Heart Study director, Robert A. Davey as NEIDL director, and Alik Farber as Surgeon-in-Chief at Boston Medical Center. Partnerships span Boston Medical Center (primary teaching affiliate), Solomon Carter Fuller Mental Health Center (psychiatry training), Harvard's Countway Library, and the Boston Library Consortium. International research collaborations extend to Israel and other geographies for genetic and epidemiological studies.

Short descriptiontext

Boston University Chobanian & Avedisian School of Medicine is a nonprofit academic medical institution founded in 1848 that delivers MD and graduate medical education to nearly 3,800 students, conducts biomedical research through facilities including NEIDL and the Framingham Heart Study, and provides clinical training via Boston Medical Center with a focus on underserved populations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical education, graduate medical sciences, biomedical research, clinical training, infectious disease research
Industry3 codes
1Medical Schools (MD/DO Granting)
CodeEDAHAGABPrimaryYes
2Academic Medical Centers & Teaching Hospitals (University-Affiliated)
CodeEDAHAGAAPrimaryNo
3Schools of Public Health
CodeEDAHAGADPrimaryNo
NAICS code2 codes
  • Colleges, Universities, and Professional Schools6113
  • General Medical and Surgical Hospitals62211
SIC code3 codes
  • Services-Hospitals8060
  • Services-Health Services8000
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Medical Education and Academic Medicine
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Education Programs
TypeSubscription Recurring
Description

Revenue from tuition and fees for MD, graduate, and professional programs in medicine and health sciences.

bumc.bu.edu
2Research Grants and Funding
TypeLicensing Royalties
Description

Federal research funding from NIH for various research initiatives including Alzheimer's disease studies, genetics research, and infectious disease work at NEIDL.

bumc.bu.edu
3Clinical Care Revenue
TypeTransaction Fee
Description

Revenue generated through clinical services at Boston Medical Center, the primary teaching affiliate, including patient care, procedures, and medical services.

news-medical.net
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Others
Pricing details1 tier
1Medical education programs with varying tuition based on program type and student status
ModelSubscriptionBilling cadenceAnnual
Notes

Tuition-based model with financial aid available for eligible students

bumc.bu.edu
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Boston University Chobanian & Avedisian School of Medicine is a private nonprofit academic medical institution that delivers MD and Graduate Medical Sciences degree programs, postdoctoral research training, and clinical medical education. The school conducts biomedical research through facilities such as NEIDL and the Framingham Heart Study, and provides clinical training at its primary teaching affiliate, Boston Medical Center. Its mission centers on serving disadvantaged, underserved, and indigent populations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Discovery of first vaccine to protect primates from Ebola virus
+2 more records
Product overview1 text field

Boston University Chobanian & Avedisian School of Medicine is an academic medical institution that provides medical education, research programs, and clinical training through its MD program, Graduate Medical Sciences division, and affiliated teaching hospital Boston Medical Center. The school offers various academic programs across multiple disciplines including medicine, public health, and dental medicine, as part of the larger Boston University Medical Campus. No distinct branded products, modules, or technology platforms with product names were identified in the source data.

Product and service6 records
1MD Degree Program
CategoryMedical Education
Description

Four-year medical degree program providing medical education and clinical training for prospective physicians, with clinical rotations at Boston Medical Center.

2Graduate Medical Sciences (GMS) Programs
CategoryGraduate Education
Description

Master's and PhD degree programs in biomedical sciences for graduate students seeking research training and academic career development.

3Clinical Training at Boston Medical Center
CategoryClinical Training
Description

Clinical residency and clerkship training at Boston Medical Center for medical students, residents, and fellows across multiple specialties.

4Framingham Heart Study Research Program
CategoryBiomedical Research
Description

Longitudinal cardiovascular epidemiology research program based on the Framingham Heart Study cohort, providing data and findings on heart disease risk factors.

5National Emerging Infectious Diseases Laboratories (NEIDL) Research
CategoryBiomedical Research
Description

Infectious disease research program housed in BSL-4-capable facilities, conducting work on Ebola, virus-host interactions, and antiviral drug discovery.

6Alumni Medical Library Services
CategoryLibrary and Information Services
Description

Library and information services providing access to 6,800+ e-journals, 12,600+ e-books, 25,000+ books, databases, and reference/research support for students, faculty, and staff.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Boston Medical Center serves as the primary teaching affiliate of the Chobanian & Avedisian School of Medicine, providing clinical training sites for medical students and residents, and is the main venue for patient care education and community health service delivery.

2Solomon Carter Fuller Mental Health Center
Strategic tierCoreTypeStrategic or Co-development Partner
Description

State mental health facility that serves as a training site for psychiatry and mental health education, part of the Boston Medical Campus ecosystem.

bumc.bu.edu
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Elite private medical school in Boston offering MD, PhD, and residency training with extensive NIH funding and a network of major teaching hospitals (MGH, Brigham and Women's). Direct geographic and structural peer of BU Chobanian & Avedisian.

TypeDirect peer
Description

Private Boston-area medical school with a comparable MD program, Graduate Biomedical Sciences division, and public-health orientation. Competes with BU for the same applicant pool and clinical training affiliates.

TypeDirect peer
Description

Private Ivy League medical school in the Northeast offering an MD program with significant NIH-funded biomedical research. Comparable in scale, mission, and applicant demographic to BU.

TypeDirect peer
Description

Top-tier private research medical school with strong NIH funding and Yale New Haven Hospital as primary teaching affiliate. Direct competitor for faculty recruitment and biomedical research grants.

TypeDirect peer
Description

Private research-intensive medical school in NYC with similar NIH-funded research scale, MD/PhD programs, and a major urban teaching hospital affiliate. Comparable in research output and applicant profile.

TypeDirect peer
Description

Private NYC medical school that pioneered fully-funded tuition, attracting top applicants. Direct competitor for MD enrollment and operates NYU Langone as its primary teaching affiliate — a structural parallel to BU/BMC.

TypeDirect peer
Description

Private NYC medical school affiliated with Cornell University and NewYork-Presbyterian Hospital. Comparable in NIH funding scale, research portfolio, and MD/PhD program structure.

TypeDirect peer
Description

Top-5 private research medical school with massive NIH funding, a large faculty, and Penn Medicine as integrated health system. Comparable in research intensity and biomedical graduate training scale.

TypeDirect peer
Description

Top-tier private research medical school consistently #1 in NIH funding, with Johns Hopkins Hospital as primary teaching affiliate. Direct peer in research output, MD/PhD training, and biomedical discovery leadership.

TypeOthers
Description

Primary teaching affiliate of BU Chobanian & Avedisian School of Medicine and a major safety-net hospital. While not a peer medical school, it is the principal clinical training site and the operational anchor for the school's clinical mission.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Boston University Chobanian & Avedisian School of Medicine

Medical Education and Academic Medicinebumc.bu.edu

Boston University Chobanian & Avedisian School of Medicine is a nonprofit academic medical institution founded in 1848 that delivers MD and graduate medical education to nearly 3,800 students, conducts biomedical research through facilities including NEIDL and the Framingham Heart Study, and provides clinical training via Boston Medical Center with a focus on underserved populations.

What Boston University Chobanian & Avedisian School of Medicine does

Boston University Chobanian & Avedisian School of Medicine is a private nonprofit academic medical institution founded in 1848 as New England's first medical school, operating within Boston University's Medical Campus in the historic South End of Boston. The school delivers medical education through MD and graduate programs (Graduate Medical Sciences), trains nearly 3,800 students, and employs 2,900+ full-time, part-time, affiliate, and volunteer faculty. Its research portfolio is anchored by flagship facilities including the National Emerging Infectious Diseases Laboratories (NEIDL), the Center for Regenerative Medicine (CReM), a cryoEM facility equipped with a Glacios-2 system, and the Framingham Heart Study, the nation's longest-running cardiovascular cohort study at 75+ years. Boston Medical Center, the school's primary teaching affiliate and a safety-net hospital, provides clinical training sites and serves as the main venue for community health service delivery focused on underserved populations.

The school's revenue model is multi-stream and characteristic of nonprofit academic medical centers: (1) tuition and fees from MD and graduate programs billed annually with financial aid support; (2) federal research funding, predominantly from NIH grants supporting work in Alzheimer's genetics, infectious diseases, and other areas; and (3) clinical care revenue flowing through Boston Medical Center as the primary teaching affiliate. The institution has secured major grant funding including a $13.7M NIH award for Alzheimer's genetic research and a $3.9M NIH grant for Alzheimer's therapeutics. A landmark $100 million naming gift from alumnus Edward Avedisian in 2022, the largest in school history, expanded endowed professorships, financial aid, and research initiatives. The school's go-to-market is direct-to-consumer in education (admissions-based enrollment) and enterprise in research (federal grants and institutional collaborations), with clinical services distributed through Boston Medical Center and affiliated community health centers including Codman Square Health Center and DotHouse Health.

The institution is led by a faculty of internationally recognized researchers, including Nobel laureate Drew Weissman (mRNA technology, 2023 Nobel Prize in Physiology or Medicine) as an alumnus and Nancy Sullivan (Ebola vaccine pioneer) as director of NEIDL. Recent strategic leadership appointments include Donald M. Lloyd-Jones as Framingham Heart Study director, Robert A. Davey as NEIDL director, and Alik Farber as Surgeon-in-Chief at Boston Medical Center. Partnerships span Boston Medical Center (primary teaching affiliate), Solomon Carter Fuller Mental Health Center (psychiatry training), Harvard's Countway Library, and the Boston Library Consortium. International research collaborations extend to Israel and other geographies for genetic and epidemiological studies.

Boston University Chobanian & Avedisian School of Medicine firmographics

Firmographics
Name
Boston University Chobanian & Avedisian School of Medicine
Legal name
Boston University Chobanian & Avedisian School of Medicine
Website
https://bumc.bu.edu
Company type
Private
Founded year
1848
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Boston University Chobanian & Avedisian School of Medicine is a nonprofit academic medical institution founded in 1848 that delivers MD and graduate medical education to nearly 3,800 students, conducts biomedical research through facilities including NEIDL and the Framingham Heart Study, and provides clinical training via Boston Medical Center with a focus on underserved populations.
Ownership category
akta.pro rank

Boston University Chobanian & Avedisian School of Medicine industry classification

Industry
Product category
Medical Education and Academic Medicine
NAICS
Colleges, Universities, and Professional Schools (6113), General Medical and Surgical Hospitals (62211)
SIC
Services-Hospitals (8060), Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro primary industry
Medical Schools (MD/DO Granting) (EDAHAGAB)
akta.pro secondary industries
Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Schools of Public Health (EDAHAGAD)

Keywords

  • Medical education
  • Graduate medical sciences
  • Biomedical research
  • Clinical training
  • Infectious disease research

Where Boston University Chobanian & Avedisian School of Medicine is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Boston University Chobanian & Avedisian School of Medicine business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Others

Revenue model

  1. Medical Education Programs: Revenue from tuition and fees for MD, graduate, and professional programs in medicine and health sciences.
  2. Research Grants and Funding: Federal research funding from NIH for various research initiatives including Alzheimer's disease studies, genetics research, and infectious disease work at NEIDL.
  3. Clinical Care Revenue: Revenue generated through clinical services at Boston Medical Center, the primary teaching affiliate, including patient care, procedures, and medical services.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualMedical education programs with varying tuition based on program type and student status

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Boston University Chobanian & Avedisian School of Medicine product offering

Product offering

Core offering

Boston University Chobanian & Avedisian School of Medicine is a private nonprofit academic medical institution that delivers MD and Graduate Medical Sciences degree programs, postdoctoral research training, and clinical medical education. The school conducts biomedical research through facilities such as NEIDL and the Framingham Heart Study, and provides clinical training at its primary teaching affiliate, Boston Medical Center. Its mission centers on serving disadvantaged, underserved, and indigent populations.

Product overview

Boston University Chobanian & Avedisian School of Medicine is an academic medical institution that provides medical education, research programs, and clinical training through its MD program, Graduate Medical Sciences division, and affiliated teaching hospital Boston Medical Center. The school offers various academic programs across multiple disciplines including medicine, public health, and dental medicine, as part of the larger Boston University Medical Campus. No distinct branded products, modules, or technology platforms with product names were identified in the source data.

Differentiator

Problem solved

Functional benefit

Products and services

  • MD Degree Program Four-year medical degree program providing medical education and clinical training for prospective physicians, with clinical rotations at Boston Medical Center.
  • Graduate Medical Sciences (GMS) Programs Master's and PhD degree programs in biomedical sciences for graduate students seeking research training and academic career development.
  • Clinical Training at Boston Medical Center Clinical residency and clerkship training at Boston Medical Center for medical students, residents, and fellows across multiple specialties.
  • Framingham Heart Study Research Program Longitudinal cardiovascular epidemiology research program based on the Framingham Heart Study cohort, providing data and findings on heart disease risk factors.
  • National Emerging Infectious Diseases Laboratories (NEIDL) Research Infectious disease research program housed in BSL-4-capable facilities, conducting work on Ebola, virus-host interactions, and antiviral drug discovery.
  • Alumni Medical Library Services Library and information services providing access to 6,800+ e-journals, 12,600+ e-books, 25,000+ books, databases, and reference/research support for students, faculty, and staff.

Quantifiable outcome

  • Discovery of first vaccine to protect primates from Ebola virus
  • +2 more outcomes

Companies that use Boston University Chobanian & Avedisian School of Medicine

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Boston University Chobanian & Avedisian School of Medicine technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Boston University Chobanian & Avedisian School of Medicine partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Boston Medical CentercoreStrategic or Co-development PartnerBoston Medical Center serves as the primary teaching affiliate of the Chobanian & Avedisian School of Medicine, providing clinical training sites for medical students and residents, and is the main venue for patient care education and community health service delivery.
  • Solomon Carter Fuller Mental Health CentercoreStrategic or Co-development PartnerState mental health facility that serves as a training site for psychiatry and mental health education, part of the Boston Medical Campus ecosystem.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Boston University Chobanian & Avedisian School of Medicine competitors and assessment

Company assessment

Direct peers

  • Harvard Medical School: Elite private medical school in Boston offering MD, PhD, and residency training with extensive NIH funding and a network of major teaching hospitals (MGH, Brigham and Women's). Direct geographic and structural peer of BU Chobanian & Avedisian.
  • Tufts University School of Medicine: Private Boston-area medical school with a comparable MD program, Graduate Biomedical Sciences division, and public-health orientation. Competes with BU for the same applicant pool and clinical training affiliates.
  • Brown University Warren Alpert Medical School: Private Ivy League medical school in the Northeast offering an MD program with significant NIH-funded biomedical research. Comparable in scale, mission, and applicant demographic to BU.
  • Yale School of Medicine: Top-tier private research medical school with strong NIH funding and Yale New Haven Hospital as primary teaching affiliate. Direct competitor for faculty recruitment and biomedical research grants.
  • Columbia University Vagelos College of Physicians and Surgeons: Private research-intensive medical school in NYC with similar NIH-funded research scale, MD/PhD programs, and a major urban teaching hospital affiliate. Comparable in research output and applicant profile.
  • NYU Grossman School of Medicine: Private NYC medical school that pioneered fully-funded tuition, attracting top applicants. Direct competitor for MD enrollment and operates NYU Langone as its primary teaching affiliate — a structural parallel to BU/BMC.
  • Weill Cornell Medicine: Private NYC medical school affiliated with Cornell University and NewYork-Presbyterian Hospital. Comparable in NIH funding scale, research portfolio, and MD/PhD program structure.
  • University of Pennsylvania Perelman School of Medicine: Top-5 private research medical school with massive NIH funding, a large faculty, and Penn Medicine as integrated health system. Comparable in research intensity and biomedical graduate training scale.
  • Johns Hopkins University School of Medicine: Top-tier private research medical school consistently #1 in NIH funding, with Johns Hopkins Hospital as primary teaching affiliate. Direct peer in research output, MD/PhD training, and biomedical discovery leadership.

Others

  • Boston Medical Center: Primary teaching affiliate of BU Chobanian & Avedisian School of Medicine and a major safety-net hospital. While not a peer medical school, it is the principal clinical training site and the operational anchor for the school's clinical mission.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Boston University Chobanian & Avedisian School of Medicine social profiles

Digital presence

Boston University Chobanian & Avedisian School of Medicine financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Boston University Chobanian & Avedisian School of Medicine leadership team

Management profile

Number of profiles

Profiles5 records

Boston University Chobanian & Avedisian School of Medicine subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Boston University Chobanian & Avedisian School of Medicine funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Boston University Chobanian & Avedisian School of Medicine M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Boston University Chobanian & Avedisian School of Medicine

What does Boston University Chobanian & Avedisian School of Medicine do?

Boston University Chobanian & Avedisian School of Medicine is a private nonprofit academic medical institution that delivers MD and Graduate Medical Sciences degree programs, postdoctoral research training, and clinical medical education. The school conducts biomedical research through facilities such as NEIDL and the Framingham Heart Study, and provides clinical training at its primary teaching affiliate, Boston Medical Center. Its mission centers on serving disadvantaged, underserved, and indigent populations.

Is Boston University Chobanian & Avedisian School of Medicine a public or private company?

Boston University Chobanian & Avedisian School of Medicine is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Boston University Chobanian & Avedisian School of Medicine founded?

Boston University Chobanian & Avedisian School of Medicine was founded in 1848. It employs 5,001 to 10,000 people.

Where is Boston University Chobanian & Avedisian School of Medicine based?

Boston University Chobanian & Avedisian School of Medicine is headquartered in Boston, United States, in the North America region.

How does Boston University Chobanian & Avedisian School of Medicine make money?

Three revenue lines are on record. Medical Education Programs are the primary driver. The others are research Grants and Funding and clinical Care Revenue.

Who are Boston University Chobanian & Avedisian School of Medicine's main competitors?

Direct peers on record are Harvard Medical School, Tufts University School of Medicine, Brown University Warren Alpert Medical School, Yale School of Medicine, Columbia University Vagelos College of Physicians and Surgeons, NYU Grossman School of Medicine, Weill Cornell Medicine, University of Pennsylvania Perelman School of Medicine and Johns Hopkins University School of Medicine. Boston Medical Center is listed as an others.

Does Boston University Chobanian & Avedisian School of Medicine have an API?

No public API is recorded for Boston University Chobanian & Avedisian School of Medicine.

What industry is Boston University Chobanian & Avedisian School of Medicine in?

Boston University Chobanian & Avedisian School of Medicine's product category is Medical Education and Academic Medicine. Its primary akta.pro industry code is EDAHAGAB, Medical Schools (MD/DO Granting), with a secondary code of EDAHAGAA, Academic Medical Centers & Teaching Hospitals (University-Affiliated). Its NAICS code is 6113 and its SIC code is 8060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Mirage NewsEditorial Backs Bedside Lumbar Punctures by Neurologists and TraineesResearchers from Boston University Chobanian & Avedisian School of Medicine published an editorial in Neurology Education advocating bedside lumbar punctures by neurologists and trainees. They cite ultrasound-guided lumbar puncture benefits from other specialties, including higher success rates and lower pain, and suggest it should be used for patients with difficult anatomy. Controlled multicenter studies are proposed to confirm outcomes.News-MedicalCGM reveals glucose patterns linked to cardiometabolic risk in adults without diabetesResearchers at Boston University analyzed CGM data from about 1,300 non-diabetic Framingham participants and found higher average glucose and more time above 140 mg/dL linked to higher hypertension and cholesterol risk. The findings suggest CGM patterns may help identify cardiometabolic risk in people without diabetes, though additional studies are needed.News-MedicalSpecialized blood vessel cells found to actively drive lung fibrosisA collaborative study from Boston University researchers identified a previously unrecognized population of specialized cells in lung veins that become active after injury and promote scar tissue formation in pulmonary fibrosis. Using genetically engineered models, the team found that inactivating LATS1/2 genes preserved normal vascular function and prevented scarring. The findings, published in Science Advances, are described as preclinical and requiring further validation.Mirage NewsBlood Vessel Cells Vary in Injury ResponseResearchers at Boston University identified a previously unrecognized population of cells in lung veins that become active after injury and promote scar tissue formation in pulmonary fibrosis. Using genetically engineered models and single-cell analysis, they found that blocking the overactive signaling pathway prevented scarring and reduced inflammation in preclinical models. The findings appear online in Science Advances.Mirage NewsRethinking Human Skeletal Biology's Gender BinaryResearchers from Boston University Chobanian & Avedisian School of Medicine published a review article arguing that traditional human skeletal biology's binary approach to sex estimation is oversimplified and potentially harmful to marginalized groups. The article contends that forensic anthropology practices reinforce faulty notions about human variation, citing examples of sexist, queerphobic, and essentialist approaches in textbooks and science communication. The researchers call for sex-expansive practices that better reflect biocultural variation while affirming LGBTQIA+ livelihoods.News-MedicalBrain transposons may influence aging and neurodegenerative disease progressionResearchers at Boston University found that transposons are actively expressed as large RNAs in human brains, which are processed into small RNAs. Huntington's disease affects transposon small RNA expression, while Parkinson's has a stronger impact on large RNAs. The findings suggest transposon RNA processing may reveal molecular differences between these disorders.Technology NetworksMosquitoes Carry More Viruses Than We ThoughtResearchers at Boston University Chobanian & Avedisian School of Medicine used RNA sequencing to analyze Aedes aegypti mosquitoes' immune responses and discovered these disease-carrying mosquitoes are infected with far more viruses than previously known, including some that can evade the mosquito's immune defense system. The study analyzed mosquitoes collected from North America, Central America, Africa and Asia, developing bioinformatics pipelines that identified distinct viral populations specific to different continents. The research team aims to use their findings to develop mosquito viruses as potential tools to inoculate mosquitoes against pathogenic arboviruses like dengue, yellow fever, chikungunya, and Zika.Axios"The Fauci effect": Medical school applications up 18% since last yearApplications to U.S. medical schools rose 18% this year, with Stanford seeing 11,000 applicants for 90 seats and Boston University 12,024 for 110. The surge may reflect the pandemic's focus on health workers, though some attribute it to more time for applications. The AAMC projects a physician shortage of 54,100–139,000 by 2033.